Skip to main content

$0.180 0.015 (9.09%)

High

$0.18

Low

$0.17

Trades

42

Turnover

$91,156

Volume

530,592
30 June 2023 at 3:58pm
Register to track NUH and receive email alerts.

NUH Commences Clinical Trial with Pathway to FDA Submission

StockBot

416,823 posts

NUH released this announcement to the ASX on 15 October 2021, 9:38. The announcement is not marked as price sensitive, and is 2 page(s) in length and 287.85kb in size.

You can view all announcements from NUH and see how they appear on a price chart on the announcements page.

At the date of this announcement, NUH was 0.418% short sold according to ASIC data. It was ranked the 305th most shorted stock on the ASX. It remains ranked 555th as of the latest reported data (28 February 2025).

Other Recent Announcements from NUH
Change in substantial holding 29 June 2023, 16:03
Change in substantial holding 20 June 2023, 9:08
Letter to Shareholders - Notice of General Meeting 16 June 2023, 16:21
NUH Commences Clinical Trial with Pathway to FDA Submission 15 October 2021, 9:38
Results of Meeting 14 October 2021, 16:02
2021 Annual General Meeting Presentation 14 October 2021, 13:41
Application for quotation of securities - NUH 5 October 2021, 20:24
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track NUH and receive email alerts.